Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Change in Cash: 2013-2024

Historic Change in Cash for Surgery Partners (SGRY) over the last 11 years, with FY2024 value amounting to $73.6 million.

  • Surgery Partners' Change in Cash fell 66265.06% to -$46.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$106.3 million, marking a year-over-year decrease of 79934.21%. This contributed to the annual value of $73.6 million for FY2024, which is 18459.77% up from last year.
  • Per Surgery Partners' latest filing, its Change in Cash stood at $73.6 million for FY2024, which was up 18459.77% from -$87.0 million recorded in FY2023.
  • In the past 5 years, Surgery Partners' Change in Cash ranged from a high of $225.2 million in FY2020 and a low of -$107.0 million during FY2022
  • For the 5-year period, Surgery Partners' Change in Cash averaged around $35.3 million, with its median value being $71.7 million (2021).
  • Its Change in Cash has fluctuated over the past 5 years, first soared by 34585.15% in 2020, then crashed by 24923.29% in 2022.
  • Surgery Partners' Change in Cash (Annual) stood at $225.2 million in 2020, then tumbled by 68.16% to $71.7 million in 2021, then tumbled by 249.23% to -$107.0 million in 2022, then grew by 18.69% to -$87.0 million in 2023, then skyrocketed by 184.6% to $73.6 million in 2024.
  • Its Change in Cash was $73.6 million in FY2024, compared to -$87.0 million in FY2023 and -$107.0 million in FY2022.